Definium Therapeutics Inc (DFTX) PT Raised to $55 at Maxim Group

August 14, 2026 8:32 AM

Maxim Group raised its price target on Definium Therapeutics Inc (NASDAQ: DFTX) to $55.00 (from $50.00) while maintaining a Buy rating.

No results found